High throughput drug profiling
2000
High Throughput Drug Profiling
Sample size: 100000
publication
Evidence: moderate
Author Information
Author(s): Michael Entzeroth, Beatrice Chapelain, Jacques Guilbert, Valerie Hamon
Primary Institution: CEREP SA
Conclusion
High throughput profiling combines conventional screening with data mining technologies to enhance drug discovery.
Supporting Evidence
- High throughput screening has significantly increased the number of samples tested in drug discovery.
- Only one out of approximately ten potential drug candidates entering phase I of development will reach the market.
- High throughput profiling allows for a comprehensive evaluation of drug candidates' properties.
Takeaway
This study shows how scientists can quickly test many drugs to find the best ones for treating diseases, making the process faster and cheaper.
Methodology
The study utilized high throughput screening and profiling to evaluate drug candidates based on their biological activity and properties.
Limitations
The study does not specify limitations but mentions the challenges of high costs and the drop-out rate of drug candidates.
Want to read the original?
Access the complete publication on the publisher's website